Fluarix Tetra / Influsplit Tetra (GSK2321138A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluarix Tetra / Influsplit Tetra (GSK2321138A), covering 2017-03-09 to 2017-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older [Phase 3]